Skip to main content

Corporate insider profile

Camille L Bedrosian Insider Trades

Latest reported as Chief Medical Officer of Amylyx Pharmaceuticals, Inc. (AMLX).

Purchase filings
0
Reported companies
1
Net open-market value
-$324,868.09
Latest transaction
Sep 10, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Sep 10, 2026Amylyx Pharmaceuticals, Inc. (AMLX)Chief Medical OfficerSale10,028$32.40$324,868